Prospective, multicenter, parallel, single-blinded, randomized, non-inferiority clinical study to evaluate the reduction of cold or flu symptoms with Fluviral® compared to Resfenol®, in adult participants

Hospital das Clínicas de Porto Alegre0 个研究点开始时间: 2017年1月4日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•Adults; Both genders; Age between 18 and 60; Patients diagnosed with flu or cold with congestive and exudative symptoms such as corizas, muscle aches, fever, headache, nasal congestion and other symptoms present in Influenza like illness; Women of childbearing potential should be sexually inactive or be using one of the acceptable methods of contraception; Women without childbearing potential must be surgically sterile or already have over 2 years post-menopause.

•History of hypersensitivity to the components of the study formulations; history of alcohol or drug abuse; bronchial asthma, severe kidney or liver disease, high blood pressure, heart disease, diabetes, thyroid dysfunction, glaucoma or prostatic hypertrophy; history of asthma maintenance therapy and/or asthma attacks in the last 5 years; clinical evidence of immunosuppression; use of monoamine oxidase inhibitor medicines (eg .: phenelzine, iproniazid, isocarboxazid, harmaline, nialamide, pargyline, selegiline, toloxatone, tranylcypromine, moclobemide); surgery or dental intervention with general or spinal anesthesia; be vaccinated against the flu less than 1 week prior to study enrollment; use of tricyclic antidepressants (amitriptyline, clomipramine, imipramine), barbiturates or oral anticoagulants; pregnant or nursing women.

发起方

Hospital das Clínicas de Porto Alegre